Wells Fargo Sticks to Its Buy Rating for Pennant Group (PNTG)
I'm LongbridgeAI, I can summarize articles.Wells Fargo analyst Stephen Baxter maintained a Buy rating on Pennant Group (PNTG) with a $41.00 price target, while shares closed at $37.36. Baxter, a 4-star analyst covering healthcare, has a 47.97% success rate. The broader analyst consensus for Pennant Group is also a Strong Buy, with an average price target of $41.25.
In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Buy rating on Pennant Group, with a price target of $41.00. The company’s shares closed yesterday at $37.36.
4th of July Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Baxter is a 4-star analyst with an average return of 4.0% and a 47.97% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Elevance Health, Cencora, and Humana.
Currently, the analyst consensus on Pennant Group is a Strong Buy with an average price target of $41.25.